| Cas No.: | 1309434-83-0 |
| Chemical Name: | N-[3-Chloro-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]phenyl]-2-pyridinecarboxamide |
| Synonyms: | ML182 |
| Formula: | C21H16ClN3O3 |
| M.Wt: | 393.827 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | VU0400195 (ML 182) is a potent, selective, brain penetrant and orally active positive allosteric modulator of mGluR4 with EC50 of 291 nM and 376 nM for human and rat mGluR4, respectively; shows no activity against mGlu1, 2, 3, and 8 and active against mGlu5 (PAM, EC50=1.7 uM), mGlu6 (PAM, EC50>10 uM) and mGlu7 (PAM, EC50=2.9 uM); reverses haloperidol-induced catalepsy, a preclinical rodent model of motor impairments associated with Parkinson’s disease. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
